0,889  0,005  Antiinflammatory
0,695  0,016  Teratogen
0,690  0,016  Embryotoxic
0,684  0,033  Apoptosis agonist
0,639  0,005  UGT1A4 substrate
0,621  0,009  Nitric oxide antagonist
0,607  0,014  CYP2C19 substrate
0,577  0,014  Antipruritic, allergic
0,560  0,005  Sigma receptor agonist
0,567  0,013  NOS3 expression inhibitor
0,578  0,031  CYP3A4 substrate
0,529  0,005  Contraceptive
0,532  0,017  CYP2C19 inhibitor
0,550  0,037  Antineoplastic (lung cancer)
0,531  0,019  Antineoplastic (cervical cancer)
0,534  0,024  Immunosuppressant
0,530  0,020  Sensitization
0,505  0,005  Abortion inducer
0,516  0,017  NOS2 expression inhibitor
0,504  0,010  UGT2B4 substrate
0,487  0,003  UGT2B9 substrate
0,478  0,008  Hair growth stimulant
0,502  0,036  CYP2C9 substrate
0,468  0,006  Antiacne
0,467  0,005  Pneumotoxic
0,502  0,046  TNF expression inhibitor
0,472  0,021  Chemopreventive
0,455  0,007  UGT2B7 substrate
0,483  0,035  Prostate cancer treatment
0,466  0,033  Bone diseases treatment
0,488  0,057  Antineoplastic (breast cancer)
0,432  0,007  Antipruritic, non-allergic
0,487  0,065  Caspase 9 stimulant
0,450  0,028  Analeptic
0,426  0,006  Endometrios treatment
0,447  0,029  AR expression inhibitor
0,443  0,029  Antineoplastic (pancreatic cancer)
0,441  0,029  Apoptosis antagonist
0,418  0,007  Lipocortins synthesis antagonist
0,414  0,004  Antiinfertility, female
0,437  0,033  Antineoplastic (melanoma)
0,457  0,054  Antibacterial
0,442  0,042  Cholesterol antagonist
0,429  0,037  Antifungal
0,401  0,013  Diuretic
0,441  0,055  Transcription factor NF kappa B inhibitor
0,425  0,040  Respiratory analeptic
0,418  0,033  Antiosteoporotic
0,413  0,042  Antihypercholesterolemic
0,373  0,004  Alcohol dehydrogenase substrate
0,391  0,028  Tumour necrosis factor alpha release inhibitor
0,366  0,005  Contraceptive male
0,374  0,013  Prostate disorders treatment
0,375  0,027  Acute neurologic disorders treatment
0,377  0,033  Proliferative diseases treatment
0,364  0,022  5 Hydroxytryptamine uptake stimulant
0,361  0,021  UGT1A1 substrate
0,360  0,025  UDP-glucuronosyltransferase substrate
0,351  0,018  Antiviral (Influenza)
0,392  0,059  Stroke treatment
0,361  0,033  Antineoplastic (osteosarcoma)
0,337  0,012  Antiviral (Influenza A)
0,355  0,031  Antineoplastic (endocrine cancer)
0,327  0,004  UGT2B10 substrate
0,352  0,038  Sodium/bile acid cotransporter inhibitor
0,350  0,038  Carcinogenic
0,328  0,019  Prostatic (benign) hyperplasia treatment
0,309  0,003  Aldosterone antagonist
0,336  0,037  Angiogenesis stimulant
0,326  0,028  Anesthetic general
0,333  0,042  Cardiovascular analeptic
0,308  0,019  Interferon gamma antagonist
0,294  0,007  Androgen antagonist
0,298  0,017  UGT2B15 substrate
0,308  0,027  Antihypotensive
0,278  0,003  Arachidonic acid antagonist
0,333  0,062  Antineoplastic (ovarian cancer)
0,295  0,025  Antialcoholic
0,345  0,083  Antileukemic
0,260  0,004  5-Alpha-reductase inhibitor
0,317  0,064  Antiepileptic
0,256  0,006  HIV-1 integrase (Strand Transfer) inhibitor
0,248  0,006  ABCA1 expression enhancer
0,246  0,005  Postmenopausal disorders treatment
0,266  0,026  Skin irritative effect
0,276  0,039  Sedative
0,242  0,007  Growth stimulant
0,295  0,063  Antioxidant
0,257  0,027  Melanin inhibitor
0,237  0,009  Contraceptive female
0,235  0,017  Cell adhesion inhibitor
0,280  0,065  Chemoprotective
0,216  0,003  Anabolic
0,219  0,007  Actinic keratosis treatment
0,291  0,080  Interleukin 2 agonist
0,289  0,078  CTGF expression inhibitor
0,217  0,009  Opioid kappa receptor antagonist
0,226  0,022  Psychosexual dysfunction treatment
0,243  0,038  Eye irritation, high
0,205  0,004  UGT2B11 substrate
0,204  0,004  Androgen agonist
0,230  0,031  Carcinogenic, group 3
0,267  0,074  UGT1A9 substrate
0,243  0,050  VCAM1 expression inhibitor
0,242  0,056  Mutagenic
0,198  0,013  Aldehyde dehydrogenase substrate
0,266  0,082  Lipoprotein disorders treatment
0,199  0,020  Microtubule formation inhibitor
0,218  0,045  Diabetic nephropathy treatment
0,174  0,004  Mineralocorticoid receptor antagonist
0,178  0,011  HIV-1 integrase (3'-Processing) inhibitor
0,263  0,096  Antipsoriatic
0,175  0,016  AMP-activated protein kinase stimulant
0,202  0,047  Succinate dehydrogenase inhibitor
0,210  0,059  Hepatoprotectant
0,170  0,020  Opioid antagonist
0,264  0,114  FMO1 substrate
0,173  0,026  Antineoplastic antibiotic
0,178  0,031  Antieczematic
0,249  0,103  Antineoplastic (colorectal cancer)
0,158  0,014  CYP2A6 inhibitor
0,166  0,023  UGT2B1 substrate
0,260  0,117  ICAM1 expression inhibitor
0,220  0,079  UGT1A6 substrate
0,147  0,006  Narcotic antagonist
0,147  0,006  Na+ K+ transporting ATPase inhibitor
0,210  0,075  Psychostimulant
0,170  0,036  Cholesterol synthesis inhibitor
0,149  0,017  Opioid mu receptor antagonist
0,189  0,058  Antimutagenic
0,180  0,050  NOS3 expression enhancer
0,238  0,110  CYP1A2 substrate
0,232  0,104  Antineoplastic (colon cancer)
0,204  0,076  Cytotoxic
0,167  0,039  Adenylate cyclase stimulant
0,147  0,024  Estrogen antagonist
0,126  0,004  Glucocorticoid antagonist
0,125  0,007  Progesterone antagonist
0,197  0,080  Neurotrophic factor enhancer
0,214  0,098  Antidiabetic symptomatic
0,201  0,086  Antiparasitic
0,127  0,012  Cushing's syndrome treatment
0,158  0,043  Antihyperlipoproteinemic
0,129  0,016  Estrogen receptor alpha antagonist
0,117  0,004  Postcoital contraceptive
0,113  0,004  Lipocortins synthesis agonist
0,145  0,041  Menstruation disorders treatment
0,174  0,073  Muscle relaxant
0,151  0,051  Pregnane X receptor agonist
0,115  0,019  Aromatase inhibitor
0,207  0,112  DNA synthesis inhibitor
0,097  0,004  Hypogonadism treatment
0,108  0,016  Ca(v)3.1 blocker
0,144  0,053  DNA polymerase I inhibitor
0,094  0,005  5-Alpha-reductase 1 inhibitor
0,239  0,150  GST A substrate
0,111  0,023  Vanilloid agonist
0,091  0,005  5-Alpha-reductase 2 inhibitor
0,152  0,067  Protein kinase stimulant
0,087  0,006  Retinoid X receptor agonist
0,124  0,043  Sulfotransferase substrate
0,144  0,064  Antifungal enhancer
0,168  0,088  Antirickettsial
0,085  0,007  RNA-directed RNA polymerase stimulant
0,095  0,018  Estrogen agonist
0,128  0,052  Antiviral (Influenza B)
0,144  0,068  Antifungal (Cryptococcus)
0,155  0,079  UGT1A3 substrate
0,187  0,115  Vasodilator
0,183  0,112  Free radical scavenger
0,094  0,025  Glycine receptor agonist
0,230  0,162  Ulceration
0,100  0,035  Antibiotic
0,099  0,035  Antiprotozoal activity enhancer
0,083  0,019  Nitric oxide donor
0,133  0,071  Anesthetic
0,116  0,054  Expectorant
0,109  0,049  Estrogen receptor beta antagonist
0,096  0,036  Glycine receptor antagonist
0,129  0,070  Antihemorrhagic
0,076  0,018  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,070  0,014  Pregnane X receptor antagonist
0,127  0,072  Vanilloid 1 agonist
0,139  0,087  Antiviral (Herpes)
0,055  0,004  Glucocorticoid agonist
0,114  0,065  Photosensitizer
0,073  0,023  Calcium channel P-type blocker
0,109  0,061  Carcinogenic, group 2B
0,130  0,083  Farnesoid X receptor antagonist
0,054  0,009  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,150  0,106  Phospholipase C inhibitor
0,166  0,122  Antiglaucomic
0,144  0,101  Antipruritic
0,075  0,034  SULT2A1 substrate
0,061  0,021  Anesthetic inhalation
0,095  0,056  SULT1E1 substrate
0,130  0,093  Genotoxic
0,173  0,137  Antineoplastic (liver cancer)
0,089  0,053  Transcription factor NF kappa B stimulant
0,165  0,130  Antineoplastic (lymphocytic leukemia)
0,068  0,034  Antimycoplasmal
0,148  0,117  Toxic, respiratory center
0,036  0,005  Corticosteroid-like
0,071  0,040  Opioid delta receptor antagonist
0,103  0,073  Mucolytic
0,110  0,081  Constipation treatment
0,185  0,157  CYP2D6 substrate
0,034  0,006  Progesterone agonist
0,051  0,023  Opioid kappa receptor agonist
0,089  0,065  Antineoplastic, alkylator
0,157  0,133  Aldehyde oxidase inhibitor
0,197  0,174  Caspase 3 stimulant
0,111  0,088  Amylase inhibitor
0,100  0,078  GABA C receptor antagonist
0,036  0,013  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,163  0,141  Cytostatic
0,142  0,120  Antihelmintic
0,195  0,175  FMO3 substrate
0,068  0,048  Andropause treatment
0,051  0,032  Factor III inhibitor
0,039  0,021  Retinoid X alpha receptor agonist
0,025  0,007  Retinoid X beta receptor antagonist
0,079  0,062  Antispirochetal
0,046  0,033  Microtubule stabilization
0,028  0,015  Retinoid X gamma receptor antagonist
0,167  0,154  Peptidyltransferase inhibitor
0,180  0,167  Flavin-containing monooxygenase substrate
0,096  0,085  SULT1A1 substrate
0,013  0,002  Transcortin receptor antagonist
0,149  0,138  Hypolipemic
0,064  0,054  Premenstrual syndrome treatment
0,037  0,027  Glucose-6-phosphate dehydrogenase inhibitor
0,112  0,103  Antineoplastic (carcinoma)
0,014  0,005  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,045  0,037  Sigma receptor antagonist
0,151  0,144  Antiprotozoal (Leishmania)
0,020  0,013  Progesterone receptor B antagonist
0,023  0,016  Retinoid X gamma receptor agonist
0,081  0,075  Triose-phosphate isomerase inhibitor
0,020  0,015  Retinoid X beta receptor agonist
0,032  0,027  Retinoid X alpha receptor antagonist
0,076  0,071  NMDA receptor antagonist
0,036  0,031  Retinoid X receptor antagonist
0,015  0,011  4-Hydroxyphenylpyruvate dioxygenase inhibitor
0,047  0,044  Protein 50S ribosomal subunit inhibitor
0,021  0,018  Vitamin D receptor antagonist
0,086  0,085  Bile acid receptor antagonist

